Physician profile
Matthew M Puc
NPI 1144278458
$27,909.77
in general payments reported to CMS, 2019-2025
16 companies · $9,591 in 2025
The $9,591 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $9.76 · 2021: $12K · 2022: $1,281 · 2023: $4,170 · 2024: $606 · 2025: $9,591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Consulting Fee: $5,500 · Food and Beverage: $1,441 · Travel and Lodging: $1,427 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Consulting Fee | $5,500.00 |
| Food and Beverage | $1,440.79 |
| Travel and Lodging | $1,426.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,556.41 | 2021-2023 | Ion, Da Vinci Surgical System, Da Vinci Sp |
| On Target Laboratories, INC | $9,367.05 | 2024-2025 | Cytalux |
| Ethicon INC. | $667.03 | 2022 | |
| Medtronic, INC. | $300.44 | 2023-2025 | Endurant Iis |
| Lemaitre Vascular, INC. | $230.98 | 2024 | Restoreflow |
| Abbott Laboratories | $152.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $132.48 | 2024 | |
| Atricure, INC. | $129.82 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Smith+Nephew, INC. | $106.03 | 2021-2024 | Pico 7 |
| Galvanize Therapeutics, INC | $102.79 | 2023 | Aliya System |
| Stryker Corporation | $74.21 | 2024 | 1788 |
| Avanos Medical | $24.90 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $22.67 | 2025 | |
| Covidien LP | $16.61 | 2019 | |
| Merck Sharp & Dohme LLC | $16.39 | 2024 | Keytruda |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $9.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Puc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.